BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1393809)

  • 21. Critical flicker fusion frequency in early chloroquine retinopathy.
    Al Khamis AR; Easterbrook M
    Can J Ophthalmol; 1983 Aug; 18(5):217-9. PubMed ID: 6627111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic findings in chloroquine maculopathy.
    Halfeld Furtado de Mendonça R; Maia OO; Yukihiko Takahashi W
    Doc Ophthalmol; 2007 Sep; 115(2):117-9. PubMed ID: 17562091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Static perimetry in chloroquine retinopathy. Perifoveal patterns of visual field depression.
    Hart WM; Burde RM; Johnston GP; Drews RC
    Arch Ophthalmol; 1984 Mar; 102(3):377-80. PubMed ID: 6703984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine toxicity despite normal dose therapy.
    Falcone PM; Paolini L; Lou PL
    Ann Ophthalmol; 1993 Oct; 25(10):385-8. PubMed ID: 8304691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
    Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
    Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
    J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maculopathy in long-term chloroquine therapy].
    Wölfelschneider P; Kohen L; Wiedemann P
    Ophthalmologe; 1998 Mar; 95(3):186-7. PubMed ID: 9578699
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A; Guillet A; Zanlonghi X; Jolliet P
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract]   [Full Text] [Related]  

  • 29. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
    Marmor MF; Chien FY; Johnson MW
    JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for antimalarial toxicity.
    Easterbrook M
    Can J Ophthalmol; 1993 Apr; 28(2):51-2. PubMed ID: 8508335
    [No Abstract]   [Full Text] [Related]  

  • 31. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the retinal toxicity of hydroxychloroquine.
    Mills PV; Beck M; Power BJ
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):109-13. PubMed ID: 6964214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular effects and safety of antimalarial agents.
    Easterbrook M
    Am J Med; 1988 Oct; 85(4A):23-9. PubMed ID: 3177429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS; Saatci OA
    Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy.
    Almony A; Garg S; Peters RK; Mamet R; Tsong J; Shibuya B; Kitridou R; Sadun AA
    Br J Ophthalmol; 2005 May; 89(5):569-74. PubMed ID: 15834087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RE: Author reply:
    Martínez-Costa L; Trentini FJ; Ibañez MV; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
    Can J Ophthalmol; 2014 Jun; 49(3):308. PubMed ID: 24862783
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chloroquine retinopathy].
    François J; de Rouck A; Cambie E; de Laey JJ
    Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
    [No Abstract]   [Full Text] [Related]  

  • 38. Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient.
    Angi M; Romano V; Valldeperas X; Romano F; Romano MR
    Int Ophthalmol; 2010 Apr; 30(2):195-7. PubMed ID: 19165421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA
    JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multimodal imaging of hydroxychloroquine and chloroquine retinopathy].
    Sellam A; Massamba N; Le Hoang P; Bodaghi B
    J Fr Ophtalmol; 2016 Jan; 39(1):111-3. PubMed ID: 26631575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.